Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
Clinical trial NCT01177384 · COMPLETED
Trial details
- NCT number
- NCT01177384
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-25
- Primary completion
- 2013-03-25
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.